Healthcare Compliance

EP4208083A1 - Philips Cardiac Output Reliability Method, April 15

The European Patent Office published patent application EP4208083A1 (Kind A1) on April 15, 2026. The invention, filed by Koninklijke Philips N.V. with inventors Laura Bogatu and Jens Muehlsteff, covers a method and apparatus for estimating the reliability of cardiac output measurements. Designated states cover all major European Patent Convention member states including DE, FR, GB, IT, NL, and ES.

EP4098180A1 - Mobile System and Auxiliary Method for Evaluating Thermographic Breast Images

The EPO published patent application EP4098180A1 on April 15, 2026, filed by Linda Canada Artificial Intelligence Inc. The application covers a mobile system and auxiliary method for evaluating thermographic breast images, with inventor DE SOUTO, Fellipe Belmino named. The published application includes IPC classifications spanning diagnostic imaging (A61B 5/01, A61B 6/00) and health informatics (G16H 30/40, G16H 50/70). The designation extends across 31 European contracting states including DE, FR, GB, IT, NL, ES, PL, and SE.

Abbott Analyte Monitoring Systems Patent Publication EP4153048A1

The European Patent Office published patent application EP4153048A1 on April 15, 2026, titled 'Systems, Devices, and Methods of Analyte Monitoring.' The applicant is Abbott Diabetes Care Inc.; inventors are Kumar and Dunn. The application covers A61B 5/00 (measuring for diagnosis) and G16H 50/20 (computing for health care). Designated states cover EU member states plus CH, LI, NO, TR, and GB.

Koh Young Technology EP4230170A1 Portable 3D Image Measuring Device Patent Published

The European Patent Office published patent application EP4230170A1 filed by Koh Young Technology Inc. for a portable three-dimensional image measuring device and three-dimensional image measuring method. The application, published April 15, 2026, covers devices and methods for capturing and processing 3D images with applications in surgical navigation and medical diagnostics. The patent is classified under IPC codes A61B 34/20, A61B 90/00, A61B 5/107, A61B 5/00, G01B 11/24, and A61B 90/30. Designated states include all EPC contracting states covering major European markets.

Stryker Patent for Visually Guiding Joint Bone Removal

The European Patent Office has published Stryker Corporation's patent application EP4106656A1, titled 'Systems and Methods for Visually Guiding Bone Removal During a Surgical Procedure on a Joint.' The invention, credited to inventors Fouts, Godbey, Zeh, and Hoffmann, covers a computer-vision and imaging-based system for real-time visual guidance of bone removal during joint surgery. The A1 publication includes the application and search report. The patent is designated across 35 European states including Germany, France, the United Kingdom, Italy, Spain, the Netherlands, and Sweden.

ECAP Detection System for Neurophysiological Diagnosis

The European Patent Office published patent application EP4153051A1 on April 15, 2026, granting intellectual property rights to Ohio State Innovation Foundation for a system detecting electrically evoked compound action potentials (ECAPs). The invention encompasses systems and computer programs for neurophysiological diagnosis applications, with inventors SKIDMORE, Jeffrey, HE, Shuman, and NING, Xia. The patent is classified under IPC category A61B covering diagnostic surgery systems and methods.

AI System Detects Human Activity via Video Signals, Medical Application

The European Patent Office published application EP4256541A1 on April 15, 2026, filed by Dignity Health for an AI system that detects human activity through video signal processing with medical applications. The system uses artificial intelligence to analyze video and other signals for activity detection, with inventors including TAKLA, George, SHIVAYOGI, Jayadev Hondadkatte, LIU, Shaung, and OROZCO, Bethel. The publication covers designated states across the European region including DE, FR, GB, IT, NL, and others.

Suntory Health Assistance Device with Diagnosis Features EP4254421A1

The European Patent Office published patent application EP4254421A1 filed by Suntory Holdings Limited for a health assistance device incorporating diagnostic features. The application covers a device, method, and recording medium for health monitoring, with inventors including YAMAMURA Junki, ZEIDA Mitsuhiro, SUZUKI Yuichi, LEE Eunseo, and TAKAGI Motoshige. The invention relates to diagnostic devices under IPC classifications including G16H (health informatics) and A61B (diagnostic measurement).

Photonic Diagnostic Method Detects Respiratory Compounds, Pathogens

EPO published patent application EP4146067A1 on April 15, 2026, covering a photonic method and apparatus for detecting compounds and pathogens in respiratory samples. The application names Jerry Aguren, John Marino, and Asma Mirza as applicants and inventors, with IPC classifications spanning A61B (diagnostics), G01N (chemical analysis), and related measurement technologies. Designated states include AT, BE, DE, ES, FR, GB, IT, NL, and 30 other European jurisdictions.

Dual Articulation Robotic Surgical Tools, EP4096558A1, Apr 15

The European Patent Office published patent application EP4096558A1 titled 'Robotic Surgical Tools Having Dual Articulation Drives' on April 15, 2026. The patent application names Cilag GmbH International as the applicant, with inventors OVERMYER, Mark D., DEFINIS, Raffaele J., and KALLENBERGER, Kris E. The invention relates to robotic surgical tools with dual articulation drives and falls under IPC classifications A61B 34/30, A61B 34/37, A61B 34/20, and A61B 90/00, covering surgical robotics technology in the medical device field.

European Patent for Male Connector Fluid Transfer Device

The EPO Patent Bulletin has published European patent application EP4260898A1 for a Male Connector and Medical Appliance. The applicant is TERUMO Kabushiki Kaisha and the inventor is KURIYAMA Tasuku. The IPC classifications A61M 39/10 and A61M 39/26 indicate this is a valve connector for medical devices. The patent application is pending in over 40 European and EPO-designated countries.

European Patent: Cell Lysis Systems and Methods, Shaheen Innovations

The European Patent Office published application EP4117462A2 on April 15, 2026. The application relates to cell lysis systems and methods invented by MACHOVEC, Jeff, ALSHAIBA SALEH GHANNAM ALMAZROUEI, Mohammed, and LAMOUREUX, Clement. The applicant is Shaheen Innovations Holding Limited.

EP4157405A1 Electromechanical Cap Remover by SHL Medical AG

The European Patent Office published patent EP4157405A1 for an electromechanical cap remover to SHL Medical AG on April 15, 2026, with inventor Antonio Farieta under IPC classifications A61M 5/32 and A61M 5/50. The patent designates protection across 31 European states including Germany, France, the United Kingdom, Italy, Spain, and others. Patent grants establish intellectual property rights but do not impose compliance obligations on third parties.

Skin Patch Drug Infusion System EP4274636A1

The European Patent Office has published patent application EP4274636A1 filed by Medtrum Technologies Inc. for a skin patch drug infusion system. The application names Cuijun Yang as inventor and covers transdermal drug delivery technology under IPC classifications including A61M 5/142 and A61B 5/145. The geographic scope includes 37 European Patent Convention contracting states including AT, BE, CH, DE, DK, ES, FI, FR, GB, IT, NL, NO, PL, SE, and others.

Sanofi Drug Delivery Device with Electronic System, EP4225406A1

The European Patent Office published Sanofi-Aventis Recherche & Developpement's European patent application EP4225406A1 on April 15, 2026. The invention relates to a drug delivery device with an electronic system, classified under IPC A61M 5/315 and A61M 5/24. The application designates all EU member states plus extended states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.

European Patent EP4208233A1, Drug Delivery System, Janssen

The European Patent Office granted Patent EP4208233A1 to JANSSEN Pharmaceutica NV on April 15, 2026, covering a drug delivery system with applications including inhalation devices (A61M 15/08), pharmaceutical compositions (A61K 31/135, A61K 31/4045, A61K 31/485), and nebulizer technology (A61M 16/16). The patent designates 36 European contracting states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands. Inventors include Emma Louise Hubert, Hong Yan, David Ramos, Shagun Popli, Steven M. Vesole, Jingli Wang, Michael Cannamela, Dolores Perez, Jimmy Cassebee, and Hoang Vinh.

Robotic, Manual Aspiration Catheters, European Patent EP4271456A1

The European Patent Office granted European Patent EP4271456A1 to Auris Health, Inc. on April 15, 2026, covering robotic and manual aspiration catheters. The patent, classified under A61M (medical preparations) and A61B (diagnosis, surgery), names six inventors and designates 31 European member states. Patent holders gain exclusive rights to manufacture, use, and commercialize the claimed catheter technology across EPO member territories.

EP4146306A1 - Capsule Device for Automatically Controlled Parenteral Injection

The European Patent Office published patent application EP4146306A1 for a capsule device designed for automatically controlled parenteral administration of medicaments performed by injection. The patent names Armando Miguel Barbosa de Abreu e Sousa as the applicant with three listed inventors and covers A61M classifications for medical injection devices including syringe and injection needle structures. The patent is now publicly available for examination, potential licensing, or opposition within the designated European member states including Germany, France, the United Kingdom, Italy, and Spain.

EP4090407A1 Guidewire Positioning, Ancora Heart

The European Patent Office published patent application EP4090407A1 titled 'Devices and Methods for Positioning a Guidewire' filed by Ancora Heart, Inc. The application, published April 15, 2026, covers guidewire positioning technology under IPC classification A61M 25/09. Designated states include all EU member states plus associated countries (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).

European Patent EP4183439A1 for Embolus Delivery System Granted to Terumo Kabushiki Kaisha

The European Patent Office published European patent application EP4183439A1 on April 15, 2026, titled 'Medical Instrument Set, Delivery System, and Embolus Delivery Medical System.' The patent has been assigned to Terumo Kabushiki Kaisha, with inventors SHIBATA, Hideaki and IKUNO, Eri. The invention falls under IPC classifications A61M 25/00, A61B 17/12, A61M 39/10, and A61B 17/00, and is validated across 35 designated EU and EEA contracting states including Germany, France, the United Kingdom, Italy, and Spain. The publication confirms that Terumo now holds exclusive rights to the embolus delivery system technology in those jurisdictions.

Devices to Support and Position an Intraocular Lens Within the Eye, Long Bridge Medical, Apr 15 2026

The European Patent Office published patent application EP4192394A1 titled 'Devices to Support and Position an Intraocular Lens Within the Eye', filed by applicant Long Bridge Medical, Inc. The application names Matthew Clarke, Ayman Naseri, and Frank Brodie as inventors, with IPC classifications A61F 2/16 and A61F 2/14 covering ophthalmic and intraocular prosthetic devices. The publication took effect on April 15, 2026. No examination or grant proceedings are reflected in this entry.

Edwards Lifesciences Prosthetic Valve Delivery Systems Patent EP4240283A1

The European Patent Office published patent application EP4240283A1 by Edwards Lifesciences Corporation for prosthetic valve delivery systems, tools, and methods for delivering implants and catheters. The application was published April 15, 2026, naming inventors Joseph Shing, James Ventress, and Andrew Gordon Method. The patent covers A61F classifications related to prosthetic heart valve delivery devices and is designated across all EPO member states.

Rhode Island Confirms Second Measles Case of 2026

The Rhode Island Department of Health has confirmed the state's second measles case of 2026. Public health authorities are likely conducting contact tracing and monitoring exposed individuals. Healthcare providers in Rhode Island should remain vigilant for additional suspected measles cases and report any compatible symptoms to state health officials.

Method and Device for Providing Alopecia Information

The USPTO granted Patent US12594023B2 to BECON CO., LTD. on April 7, 2026, covering a method and device for providing alopecia information. The patented method involves obtaining a user head image, extracting feature points and boundary points corresponding to hair and forehead regions, calculating a top-face portion value and a middle-bottom-face portion value based on distances between feature points, and generating hair loss state information based on the ratio of those values. The patent contains 10 claims and is classified under CPC codes A61B 5/448 and G16H 30/40.

DexCom Design Patent for Combination Medical Device Receiver and Display, Apr 07

USPTO granted DexCom, Inc. Design Patent USD1121822S1 for a combination medical device receiver and display. The patent, filed on October 15, 2024 (Application No. 29968267), was issued with one claim. Inventors are Young Woo Lee and Bobby Davis.

Rabid Raccoon Confirmed in Lancaster County; One Pet Exposed

A raccoon found near New Hope and Beaker roads in Heath Springs, S.C. tested positive for rabies on April 23, 2026, after being submitted for testing on April 22, 2026. One dog was exposed to the rabid raccoon and will be quarantined as required under the South Carolina Rabies Control Act. No human exposure has been reported at this time. This raccoon is the first animal to test positive for rabies in Lancaster County in 2026, and the 27th confirmed rabies case statewide this year. The public is advised to report animal bites, scratches, and exposures to potentially rabid animals to DPH and to seek medical attention if exposed.

Puerto Rico State Plan OSHA Federal Enforcement Changes 2025

OSHA has approved revisions to the Puerto Rico State Plan's Operational Status Agreement (OSA), transferring federal enforcement authority over private-sector employees on federal properties and marine construction back to federal OSHA. The new OSA, signed September 25, 2025, replaces the December 8, 1981 agreement and also clarifies coverage for military installations, USPS contractors, and aircraft cabin crew. Puerto Rico State Plan (PR OSHA) retains authority for private-sector employers generally but loses coverage for the specified federal property and marine construction contexts.

Hemostatic Device, TERUMO, Granted Apr 21

USPTO granted US Patent No. 12,605,165 (B2) to TERUMO KABUSHIKI KAISHA on April 21, 2026, for a hemostatic device comprising a tube fixing portion with first and second members, a slit portion, and a tube holding portion. The patent application No. 18507779 was filed on November 13, 2023, and the granted patent contains 20 claims. The device relates to hemostatic mechanisms using an inflatable member and tube fixing components for medical applications.

Amgen Granted Design Patent for Handheld Drug Delivery Device

Amgen Inc. has been granted US Design Patent USD1123151S1 for a handheld drug delivery device. The patent has 1 claim and covers a design for a drug delivery device classified under CPC codes A61M 5/3156, A61M 5/31591, A61M 5/3155, A61M 5/3157, A61M 5/24, A61M 5/31501, A61M 5/31551, and A61M 5/31585. The application was filed on January 7, 2025, with Application No. 29982678, and the patent issued on April 21, 2026.

NIH-Funded Trial Finds No Difference Between IV Fluids for Pediatric Septic Shock

A large NIH-supported clinical trial enrolled over 9,000 participants across five countries and found no significant difference between balanced crystalloid fluid and 0.9% saline solution for pediatric septic shock. The study found no differences in mortality, persistent kidney dysfunction, or new renal replacement therapy between the two treatment groups. Participants in both groups achieved a median of 23 hospital-free days during the 28 days following enrollment.

CMS Seeks Public Comments on Information Collection Under OMB Control No. CMS-10450

CMS published a Federal Register notice on April 27, 2026, requesting public comments on information collection activities under OMB Control No. CMS-10450 (Document Identifier CMS-10450, Citation 91 FR 22536). The notice states the comment period ends in 62 days, on June 26, 2026. Comments submitted will be considered public and posted online on Regulations.gov once reviewed by the Department of Health and Human Services.

CMS Information Collection Submission for OMB Review Under PRA

CMS submitted an information collection to the Office of Management and Budget (OMB) for review under the Paperwork Reduction Act. The document, identified as CMS-10945 and cited at 91 FR 22537, requests public comments on the collection activities. The comment period closes on May 27, 2026 (32 days from publication). Comments may be submitted via Regulations.gov or directly through the Federal Register.

USDA Announces FSIS Reorganization, National Food Safety Center in Iowa

USDA announced on April 23, 2026, an FSIS reorganization to modernize operations and establish a new National Food Safety Center in Urbandale, Iowa, as the agency's primary hub for administrative and support operations, with expanded scientific capabilities at a new Science Center in Athens, Ga. FSIS clarified that frontline food safety inspection activities and personnel are unaffected, with no reduction in force. The update also publishes the FY 2025 Sampling Summary report and announces open comment periods through May 26, 2026, for renewal of approved information collections covering nutrition labeling, public health information systems, new technology notifications, and voluntary destruction procedures.

National Institute on Deafness and Other Communication Disorders Advisory Council Meeting

The National Institute on Deafness and Other Communication Disorders (NIDCD), a component of the NIH, has published a Federal Register notice announcing a public meeting of the National Deafness and Other Communication Disorders Advisory Council on May 14, 2026 from 9:30 a.m. to 12:50 p.m. The open session will include a staff report. Portions of the meeting will be closed to the public pursuant to 5 U.S.C. sections 552b(c)(4) and 552b(c)(6) to discuss grant applications containing confidential trade secrets, commercial property such as patentable material, and personal information of individuals associated with the applications. Individuals requiring special assistance such as sign language interpretation should contact the listed Contact Person in advance.

Center for Scientific Review; Notice of Closed Meetings

The National Institutes of Health published a notice on April 27, 2026 announcing a closed meeting of the Center for Scientific Review Special Emphasis Panel scheduled for May 28, 2026 from 12:00 p.m. to 3:00 p.m. The virtual meeting will review and evaluate grant applications. The meeting is closed pursuant to 5 U.S.C. sections 552b(c)(4) and 552b(c)(6) because grant applications and discussions could disclose confidential trade secrets, commercial property such as patentable material, and personal information concerning individuals associated with the applications. Contact: Sudhirkumar U. Yanpallewar, MD, Scientific Review Officer, Center for Scientific Review, NIH, (301) 435-5000.

NICHD Board of Scientific Counselors Meeting Scheduled for April 27

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has issued a notice of meeting for its Board of Scientific Counselors pursuant to the Federal Advisory Committee Act. The meeting will be open to the public with attendance limited to space available, and a portion will be closed to the public for the review and evaluation of individual grant applications under 5 U.S.C. sections 552b(c)(4) and 552b(c)(6). Individuals requiring special assistance such as sign language interpretation must notify the Contact Person in advance of the meeting.

VRBPAC Meeting on 2026-2027 COVID-19 Vaccine Composition

The FDA announced a public meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) scheduled for May 28, 2026, from 8:30 a.m. to 4:30 p.m. Eastern Time, to discuss and provide recommendations on the composition of COVID-19 vaccines for the 2026-2027 formula. The agency is establishing Docket No. FDA-2026-N-3962 to collect public comments on the vaccine composition. The meeting will be conducted via online teleconferencing and/or video conferencing platform and is open to public participation.

FDA Renews Anesthetic and Analgesic Drug Products Advisory Committee Through May 2027

The FDA has renewed the Anesthetic and Analgesic Drug Products Advisory Committee, extending its authority beyond the May 1, 2026 expiration date. The Commissioner has formally determined that renewal is in the public interest. This committee advises the agency on scientific, medical, and technical matters related to anesthetic and analgesic drug products. The renewal maintains the committee's structure for another two years.

KDHE Rescinds Boil Water Advisory for Uniontown, Bourbon County, Kansas

The Kansas Department of Health and Environment has rescinded a boil water advisory for the City of Uniontown public water supply system in Bourbon County. The original advisory was issued due to a waterline break that caused loss of pressure in Fort Scott's distribution system, which may have resulted in bacteriological contamination. Laboratory testing of drinking water samples collected from the Uniontown system confirmed no evidence of contamination, and all conditions that placed the system at risk have been resolved.

Do Not Drink Order Rescinded for City of Sylvia, Reno County

KDHE has rescinded a Do Not Drink Order for the City of Sylvia public water supply system in Reno County following laboratory testing that found no evidence of bacteriological contamination. The original order was issued due to a loss of pressure from a water line break that could have allowed bacterial contamination. However, KDHE continues to warn that elevated nitrates remain in the well water, and customers should not give the water to infants under six months of age or boil the water, as boiling concentrates nitrates instead of reducing them.

Boil Water Advisory Issued for Seven Winds RV Park, Seward County

KDHE has issued a boil water advisory for the Seven Winds RV Park public water supply system in Seward County, Kansas, effective April 24, 2026. The advisory was triggered by a positive bacteriological sample indicating potential bacterial contamination. Customers are advised to boil water for one minute prior to drinking or food preparation, dispose of ice cubes, and disinfect dishes using a bleach solution. The advisory will remain in effect until KDHE issues a rescind order following laboratory testing that confirms safe water quality.

symplr PSO Voluntary Relinquishment and Delisting by AHRQ

AHRQ accepted a voluntary relinquishment notification from symplr PSO (PSO number P0262) and delisted the organization from the Patient Safety Organization list effective April 8, 2026 at 12:00 Midnight ET. This delisting removes symplr PSO's ability to receive privileged and confidential patient safety work product under the Patient Safety Act framework. The directories for both listed and delisted PSOs are maintained and reviewed weekly by AHRQ.

UN Controls Three Synthetic Drugs, Reviews Coca Leaf

The United Nations Commission on Narcotic Drugs (CND) placed three harmful synthetic substances under international control at its 69th session held March 9-13, 2026. The scheduling includes two synthetic opioids—N-pyrrolidino isotonitazene and N-desethyl etonitazene—added to Schedule I of the 1961 Convention, and MDMB-FUBINACA, a synthetic cannabinoid added to Schedule II of the 1971 Convention. Countries are now required to apply control measures to these substances. The CND also confirmed maintaining coca leaf in Schedule I, preserving culturally protected traditional uses while addressing illicit cocaine production risks.

WHO Prequalifies First Malaria Treatment for Newborns and Infants, Adds Diagnostic Tests

WHO announced on 24 April 2026 the prequalification of the first antimalarial treatment designed specifically for newborns and young infants weighing between two and five kilograms. The newly prequalified treatment, artemether-lumefantrine, will enable public sector procurement for approximately 30 million babies born each year in malaria-endemic areas of Africa. WHO also prequalified three new rapid diagnostic tests on 14 April 2026 designed to address pf-hrp2 gene deletions that cause false-negative results in existing HRP2-based tests, with up to 80% of cases missed in some Horn of Africa countries.

Fisher Paykel Gas Therapy Device Patent EP4275733A2

Fisher & Paykel Healthcare Limited has been granted European Patent EP4275733A2 for a substance delivery arrangement for gas therapy devices, published on April 15, 2026. The inventors are Robert Stuart Kirton, Kevin Peter O'Donnell, Martin Paul Friedrich Kramer, and Stanislav Tatkov. The patent covers multiple IPC classifications relating to respiratory therapy equipment including A61M 16/08, A61M 16/14, and A61M 16/12.

Bayer Healthcare - EP4249018A2 - Quick Release Plunger

The European Patent Office published application EP4249018A2 for a quick release plunger for medical syringes, filed by Bayer Healthcare LLC. The inventors are Kevin P. Cowan, Edward J. Rhinehart, and Mark Trocki, classified under IPC codes A61M 5/32, A61M 5/50, and A61M 5/315. The application designates all EU member states as participating countries and was published on April 15, 2026.

Milton Roy Peristaltic Pump Offset Rotor Assembly Patent EP4306804A2

The European Patent Office published patent application EP4306804A2 for Milton Roy, LLC, covering a peristaltic pump offset rotor assembly. The application names Hannah, Gary, Dunn, and Bryan as inventors and classifies the invention under IPC codes F04B 43/12 and A61M 60/279, indicating a medical device with pumping and fluid-handling applications. The patent designates 33 European contracting states including Germany, France, the United Kingdom, Italy, and Spain. Medical device manufacturers developing or commercializing peristaltic pump technology should review the claims of EP4306804A2 for potential infringement exposure. Competitors active in this space should conduct clearance searches and freedom-to-operate analyses before launching products with offset rotor assemblies in the designated contracting states.

Ypsomed AG Fluid Injector Patent EP4548947A1

Ypsomed AG obtained European Patent EP4548947A1 for a fluid injector device, published on April 15, 2026. The patent names Peter Loser, Markus Tschirren, and Christian Schrul as inventors, with classifications under A61M 5/20 and A61M 5/32. The patent designates 36 European states including all EU member states plus Switzerland, Norway, Turkey, and the United Kingdom. This is a routine intellectual property publication that grants enforceable patent rights to the applicant but does not impose compliance obligations on third parties.

Patent EP4306150A1 Published - Sanofi Stopper Device

The European Patent Office published EP4306150A1 on April 15, 2026, granting Sanofi a patent for a stopper device (IPC classification A61M 5/315). The patent names Bernd Kuehn as the sole inventor and designates 41 contracting states across Europe including DE, FR, GB, IT, ES, NL, and others. This is a routine IP grant event with no compliance obligations imposed on third parties.

Antares Pharma Needle-Assisted Jet Injection Device for Testosterone Composition

The EPO published European patent application EP4186545A1 for Antares Pharma, Inc., titled 'Needle Assisted Jet Injection Administration of Testosterone Compositions,' on April 15, 2026. The application covers jet injection devices and methods for administering testosterone compositions, with IPC classifications spanning A61M (medical devices) and A61K (pharmaceuticals). The patent application designates 31 European contracting states including Germany, France, the United Kingdom, Italy, Spain, and others.